USPTO serial 79308590
DEBERZA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Aug 10, 2021
- Examiner
- EISNACH, MICHAEL PATRICK
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with DEBERZA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $299*
Plus Government fees of $325
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical, veterinary and sanitary preparations, namely, pharmaceutical preparations for treating diabetes, pharmaceutical preparations for treating skin disorders, pharmaceutical preparations for wounds, pharmaceutical preparations for the treatment of kidney diseases, veterinary preparations for treatment of intestinal bacteria, veterinary vaccines, sanitary napkins, sanitary preparations for medical use; dietetic foods adapted for medical purposes; dietetic beverages adapted for medical purposes; oiled paper for medical purposes; gauze for dressings; empty capsules for pharmaceuticals; ear bandages, namely, surgical bandages for use on the ear, bandages for skin wounds of the ear; eye patches for medical purposes; menstruation bandages; menstruation tampons; sanitary napkins; sanitary panties; absorbent cotton, namely, absorbent cotton for medical purposes, absorbent antiseptic cotton, cotton wool for medical purposes; adhesive plasters, namely, medical plasters, sticking plasters for medical use, medical and surgical plasters; bandages for dressings; collodion for pharmaceutical purposes; breast-nursing pads; anti-diabetic pharmaceuticals; anti-diabetic preparation; pharmaceutical preparations for treating diabetes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 10, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 10, 2023 | CORN | CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Apr 10, 2023 | CORN | CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Oct 29, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Oct 24, 2021 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Oct 24, 2021 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Sep 28, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 28, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 9, 2021 | GPAR | GRANT OF PROTECTION CREATED, TO BE SENT TO IB | — |
| Aug 10, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 25, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 5, 2021 | NPUB | NOTICE OF PUBLICATION | — |
| Apr 20, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 20, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 20, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 14, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 13, 2021 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Apr 8, 2021 | SDRC | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | — |